Depreciation of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
TC BioPharm (Holdings) plc annual and quarterly Depreciation in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Depreciation for the quarter ending 31 Mar 2024 was £114,745, a 32% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Depreciation for 2024 was £383,587, a 36% decline from 2023.
  • TC BioPharm (Holdings) plc annual Depreciation for 2023 was £596,726, a 16% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (GBP)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (GBP)
Depreciation, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Depreciation (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 £383,587 -£213,139 -36% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 £596,726 -£117,824 -16% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 £714,550 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Depreciation (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 £114,745 -£54,410 -32% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 £169,155 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.